Pancreatic Cancer Research

ResearcherUniversity of PittsburghNo recent work listed

İbrahim Halil Şahin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2758-3077; OpenAlex author ID A5038480060. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 3 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers

Papers 13

  1. Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine. Last author DOI 10.1016/j.clcc.2022.11.001↗
  2. Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1177/10732748231219069↗
  3. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma. First author DOI 10.1186/s12885-021-08123-w↗
  4. The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship. Last author DOI 10.20517/cdr.2020.48↗
  5. Pancreatic cancer microenvironment: a current dilemma. First author DOI 10.1186/s40169-019-0221-1↗
  6. Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Co-author DOI 10.1158/1078-0432.ccr-17-3099↗
  7. Molecular Profiling of Pancreatic Cancer Patients-Letter. Co-author DOI 10.1158/1078-0432.ccr-18-2255↗
  8. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior. Co-author DOI 10.1186/s12885-018-4679-9↗
  9. Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity? Co-author DOI 10.1093/annonc/mdx503↗
  10. Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy. Co-author DOI 10.1517/14728222.2016.1094057↗
  11. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches. Co-author DOI 10.1586/17474124.2016.1153424↗
  12. Comment on: α-smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study. Co-author DOI 10.1038/bjc.2014.663↗
  13. Association of diabetes and perineural invasion in pancreatic cancer. Co-author DOI 10.1002/cam4.43↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eileen Mary O'Reilly · 6 shared papers, 2016–2021 · strength 0.57
  2. Christine A. Iacobuzio–Donahue · 4 shared papers, 2016–2021 · strength 0.37
  3. Marinela Capanu · 3 shared papers, 2018–2021 · strength 0.31
  4. Burak Uzunparmak · 2 shared papers, 2015–2019 · strength 0.31
  5. Harold Kunal Elias · 2 shared papers, 2018 · strength 0.28
  6. Rüveyda Ayasun · 1 shared paper, 2023 · strength 0.26
  7. Gökçe Aşkan · 2 shared papers, 2017–2021 · strength 0.24
  8. Michael David Chuong · 1 shared paper, 2023 · strength 0.17
  9. Russell F. Palm · 1 shared paper, 2023 · strength 0.17
  10. Jessica M. Frakes · 1 shared paper, 2023 · strength 0.17
  11. Samantha Webking · 1 shared paper, 2023 · strength 0.17
  12. Sarah E. Hoffe · 1 shared paper, 2023 · strength 0.17
  13. Irem Sahin · 1 shared paper, 2020 · strength 0.16
  14. Olca Baştürk · 1 shared paper, 2021 · strength 0.14
  15. Aslihan Yavas Can · 1 shared paper, 2021 · strength 0.14
  16. Zsofia Kinga Stadler · 2 shared papers, 2016–2018 · strength 0.13
  17. Erin E. Salo‐Mullen · 2 shared papers, 2016–2018 · strength 0.13
  18. David Paul Kelsen · 2 shared papers, 2016–2018 · strength 0.13
  19. Maeve Aine Lowery · 2 shared papers, 2016–2018 · strength 0.13
  20. Anna M. Varghese · 1 shared paper, 2018 · strength 0.07
  21. Zishuo I. Hu · 1 shared paper, 2018 · strength 0.07
  22. Leonard B. Saltz · 1 shared paper, 2018 · strength 0.07
  23. Luis Alberto Diaz · 1 shared paper, 2018 · strength 0.07
  24. Kenneth H. Yu · 1 shared paper, 2018 · strength 0.07
  25. James L. Abbruzzese · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.